DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Drug: Tobacco free snuff

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 138

Registration Number: NCT00218270

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Phase 1

Completed

Conditions: Mental Disorders
Dual Diagnosis
Substance-Related Disorders

Interventions: Behavioral: Standard psychiatric day treatment
Behavioral: Double Trouble in Recovery

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 229

Registration Number: NCT00218582

Locations: 🇺🇸
Albert Einstein Dept of Psychiatry, Bronx, New York, United States

Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia
Tobacco Use Disorder

Interventions: Drug: 300 mg/day bupropion-sr
Drug: 0 mg/day bupropion-sr

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 48

Registration Number: NCT00218231

Locations: 🇺🇸
Providence VA Medical Center, RI, Providence, Rhode Island, United States
🇺🇸
Brown University, Providence, Rhode Island, United States

Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use

Phase 1

Completed

Conditions: Tobacco Use Disorder

Interventions: Other: Lower Nicotine Smokeless Tobacco Product
Other: Behavioral Counseling

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 56

Registration Number: NCT00218244

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1

Phase 2

Completed

Conditions: Tobacco Use Disorder
Smoking Cessation

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Registration Number: NCT00218140

Locations: 🇺🇸
University, Richmond, Virginia, United States

Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals

Phase 1

Terminated

Conditions: Cocaine-Related Disorders
Cocaine Abuse

Interventions: Drug: GBR 12909

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 3

Registration Number: NCT00218049

Locations: 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States

Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals

Completed

Conditions: Heroin Dependence
Opioid-Related Disorders

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 16

Registration Number: NCT00218309

Locations: 🇺🇸
Wayne State University, Detroit, Michigan, United States

Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia

Not Applicable

Completed

Conditions: Opioid-Related Disorders
Hyperalgesia

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 60

Registration Number: NCT00218374

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2

Completed

Conditions: Breast Feeding
Opioid-Related Disorders

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 25

Registration Number: NCT00218010

Locations: 🇺🇸
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States

Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1

Not Applicable

Completed

Conditions: Depressive Disorder, Major
Hepatitis C

Interventions: Behavioral: Cognitive behavioral treatment for depression

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 42

Registration Number: NCT00218556

Locations: 🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy